Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission

It has been previously shown that antibiotics given before hospitalization significantly reduce the proportion of positive blood cultures in community -acquired pneumonia (CAP). The aim of this prospective study was to compare the utility and cost-benefits of blood cultures in patients, hospitalized for moderate CAP. who had or had not received antibiotic therapy prior to a dmission. During 1 year. 53 patients were included and separated into two groups: gro up 1 patients had not received antibiotic treatment prior to admission (n = 30), whereas group 2 patients had been treated with antibiotics (n = 23). Within the first 48 hours, a set of blood cultures was collected if the bod y temperature was higher than 38.5 degrees C or in the case of shaking chil ls. A total of 136 blood cultures was collected: 74 in group 1 and 62 in group 2. Bacteraemia was significantly more frequent in group 1 than in group 2, 5/30 patients vs. 0/23, respectively (P < 0.05). The cost of negative blood cultures was valued at 13,939.2 FF in group 1 and 13,164.8 FF in group 2, respectively 464.6 +/- 244.3 FF and 569.3 +/- 233.4 FF per patient (n.s.). Moreover. blood cultures rr ere the method of diagnosis in only one of the five patients with bacteraemia and in no case did a positive blood-culture result influence the initial therapeutic regime. Thus, our results suggest a reduced clinical utility and cost-benefit of bl ood cultures in patients hospitalized for moderate CAP who have received an antibiotic treatment prior to admission.